ESMO Immuno-Oncology Congress 2018: Industry Participation

ESMO Congress on Immuno-Oncology 2018

The ESMO Immuno-Oncology Congress 2018, is a highly-focused meeting devoted entirely to the development and use of immunotherapies against cancer.

We are again expecting a strong international presence and the congress will serve as a unique educational platform for our immuno-oncology community.

The Scientific Committee has planned a comprehensive and exciting educational programme that explores all the most important aspects of immuno-oncology.

How can I participate in the ESMO Congress on Immuno-Oncology 2018?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.

Contact the ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Official Italian agency for AIFA procedure

AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.

Any pharmaceutical company supporting supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.

Contact: Valentina Disabato/ Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan, Italy
Tel: +39 02 56601.1
Fax: +39 02-70048585
E-mail:  aifa@aimgroup.eu

Preparatory Information

To get up to speed with your preparation for ESMO Immuno-Oncology Congress 2018, please download our Industry Guidelines below.